Analysts’ Updated EPS Estimates for April, 24th (ACSO, ANTO, BOO, BURL, HILS, HXL, ITV, ORCH, PRTC, RDI)
Accesso Technology Group (LON:ACSO) had its buy rating reaffirmed by analysts at Peel Hunt.
Antofagasta (LON:ANTO) had its hold rating reiterated by analysts at Peel Hunt.
Burlington Stores (NYSE:BURL) had its hold rating reissued by analysts at Guggenheim. The analysts wrote, “We have a favorable view of Mr. O’Sullivan. The company also provided an updated 1Q19 outlook; we revise our estimates lower following the update. We continue to favor the off-price sector and expect share gains in 2019 but remain NEUTRAL on BURL, in part due to valuation, with BUY ratings on TJX and ROST. After the close, BURL announced a leadership succession plan, including that CEO, will step down as CEO in >10 years in that role. During his tenure, BURL has delivered solid comp sales growth and returns since the company’s IPO in 2013. Michael O’Sullivan, former President and COO at ROST, will join BURL as CEO in Sept 2019.””
Hill & Smith (LON:HILS) had its buy rating reiterated by analysts at Peel Hunt.
Hexcel (NYSE:HXL) had its buy rating reissued by analysts at Cowen Inc. They currently have a $75.00 target price on the stock.
ITV (LON:ITV) had its buy rating reissued by analysts at Liberum Capital.
Liberum Capital started coverage on shares of Orchard Funding Group (LON:ORCH). The firm issued a buy rating and a GBX 119 ($1.55) price target on the stock.
PureTech Health (LON:PRTC) had its buy rating reissued by analysts at Peel Hunt.
RDI Reit (LON:RDI) had its under review rating reissued by analysts at Peel Hunt.
Snap (NYSE:SNAP) had its hold rating reiterated by analysts at SunTrust Banks, Inc.. SunTrust Banks, Inc. currently has a $11.00 target price on the stock. The analysts wrote, “We adjust our estimates and PT to $11 (from $8) on better 1Q19 financial results and user metrics. While management remains non committal to its timing for profitability, its strong 100%+ flow through of incremental revenue to adj. EBITDA for the second quarter in a row leads us to believe that adj. EBITDA profitability could be reached as early as 4Q19. 1Q19 Results Better Than Expected. Snap beat Street expectations for both the top and bottom lines, while showing positive user trends and 2Q19 guidance (at the midpoint, guidance is higher than current consensus). 1Q19 revenue and adj. EBITDA were $320.4M/($123.4M) vs. Street consensus of $305.7M/ ($144.0M), and a prior guidance range of $285-310M/($165M)-($140M). The bottom line beat was particularly notable given that it was the second quarter with over 100% flow through from revenue to adj.””
Shield Therapeutics (LON:STX) had its buy rating reaffirmed by analysts at Peel Hunt.
Wandisco (LON:WAND) had its buy rating reiterated by analysts at Peel Hunt.
Majestic Wine (LON:WINE) had its buy rating reissued by analysts at Liberum Capital.
Receive News & Ratings for Accesso Technology Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accesso Technology Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.